School of Medicine

Biomedical engineer Hong Chen at the McKelvey School of Engineering will use a $2.1 million grant from the National Institutes of Health (NIH) to find noninvasive tools to treat the brain.

Melissa Rockwell-Hopkins, whose position has her overseeing more than $1 billion in construction projects at the School of Medicine, has been named the school’s associate vice chancellor for operations and facilities management.

Washington University School of Medicine will serve as the data and administrative coordinating center for a national effort to investigate how variations in the human genome sequence affect how the genome functions. Such information is critical for understanding human health and diseases.

A new study into cognitive control from the lab of Todd Braver promises to be the first of many aimed at understanding its origins in the brain and its variations between people and among groups.

Jeff M. Michalski, MD, the Carlos A. Perez Distinguished Professor and vice chair and director of clinical programs in the Department of Radiation Oncology at the School of Medicine, has been elected president-elect of the American Society for Radiation Oncology board of directors.

Janice L. Robertson, assistant professor of biochemistry and molecular biophysics at the School of Medicine, received a four-year $1.39 million renewal grant from the National Institute of General Medical Sciences of the National Institutes of Health (NIH) for her research titled “Driving forces of membrane protein assembly in membranes.”

The School of Medicine is accepting applications for the American Cancer Society Institutional Research Grant to support junior faculty conducting cancer research pilot projects.

A study by researchers at Washington University School of Medicine and the Veterans Affairs St. Louis Health Care System shows that people who have had COVID-19, including those with mild cases, are at an increased risk of developing kidney damage as well as chronic and end-stage kidney diseases.

With a goal of developing rheumatoid arthritis therapies with minimal side effects, School of Medicine researchers have genetically engineered cells that, when implanted in mice, will deliver a biologic drug in response to inflammation.

A study led by Washington University School of Medicine, in collaboration with the Special School District of St. Louis County, found that rapid saliva test screenings contributed to exceedingly low transmission of the virus that causes COVID-19 among students, teachers and staff in those schools.